IRIS Accounts Production v23.2.0.158 11810677 Board of Directors 1.4.22 31.3.23 31.3.23 0 0 false true false false true false 26934 6439 61789 57807 64312 37312 24411 26934 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118106772022-03-31118106772023-03-31118106772022-04-012023-03-31118106772021-03-31118106772021-04-012022-03-31118106772022-03-3111810677ns10:Originalns15:EnglandWales2022-04-012023-03-3111810677ns14:PoundSterlingns10:Original2022-04-012023-03-3111810677ns10:Originalns10:Director12022-04-012023-03-3111810677ns10:Original2022-04-012023-03-3111810677ns10:Original2023-03-3111810677ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111810677ns10:Originalns10:SmallEntities2022-04-012023-03-3111810677ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111810677ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111810677ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3111810677ns10:Originalns10:FullAccounts2022-04-012023-03-3111810677ns10:Original2021-04-012022-03-3111810677ns10:Original42ns10:Director22022-03-3111810677ns10:Original42ns10:Director22021-03-3111810677ns10:Original42ns10:Director22022-04-012023-03-3111810677ns10:Original42ns10:Director22021-04-012022-03-3111810677ns10:Original42ns10:Director22023-03-3111810677ns10:Original42ns10:Director22022-03-3111810677ns10:Originalns10:Director22022-04-012023-03-3111810677ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111810677ns10:Original2022-03-3111810677ns10:Originalns5:CurrentFinancialInstruments2023-03-3111810677ns10:Originalns5:CurrentFinancialInstruments2022-03-3111810677ns5:ShareCapitalns10:Original2023-03-3111810677ns5:ShareCapitalns10:Original2022-03-3111810677ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3111810677ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3111810677ns10:Originalns5:PlantMachinery2022-04-012023-03-3111810677ns10:Originalns5:PlantMachinery2022-03-3111810677ns10:Originalns5:PlantMachinery2023-03-3111810677ns10:Originalns5:PlantMachinery2022-03-3111810677ns10:Originalns5:AdditionsToInvestments2023-03-3111810677ns10:Originalns5:DisposalsRepaymentsInvestments2023-03-3111810677ns10:Originalns5:CostValuation2023-03-3111810677ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3111810677ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3111810677ns10:Original1ns10:Director12022-03-3111810677ns10:Original1ns10:Director12021-03-3111810677ns10:Original1ns10:Director12022-04-012023-03-3111810677ns10:Original1ns10:Director12021-04-012022-03-3111810677ns10:Original1ns10:Director12023-03-3111810677ns10:Original1ns10:Director12022-03-31
REGISTERED NUMBER: 11810677 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 March 2023

for

KDW ANAESTHESIA LTD

KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


KDW ANAESTHESIA LTD

Company Information
for the Year Ended 31 March 2023







DIRECTORS: K D Welsh
S Welsh





REGISTERED OFFICE: South Cottage
Cocksford
Stutton
Tadcaster
North Yorkshire
LS24 9NG





REGISTERED NUMBER: 11810677 (England and Wales)





ACCOUNTANTS: BK Plus Ltd
52 St Johns Lane
Halifax
West Yorkshire
HX1 2BW

KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,736 3,162
Investments 5 - -
1,736 3,162

CURRENT ASSETS
Debtors 6 49,152 59,493
Investments 7 21,383 -
Cash at bank 23,193 56,013
93,728 115,506
CREDITORS
Amounts falling due within one year 8 16,920 34,578
NET CURRENT ASSETS 76,808 80,928
TOTAL ASSETS LESS CURRENT LIABILITIES 78,544 84,090

PROVISIONS FOR LIABILITIES 694 601
NET ASSETS 77,850 83,489

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 77,750 83,389
SHAREHOLDERS' FUNDS 77,850 83,489

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 November 2023 and were signed on its behalf by:





K D Welsh - Director


KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

KDW Anaesthesia Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - Straight line over 4 years and Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 7,003
Additions 319
At 31 March 2023 7,322
DEPRECIATION
At 1 April 2022 3,841
Charge for year 1,745
At 31 March 2023 5,586
NET BOOK VALUE
At 31 March 2023 1,736
At 31 March 2022 3,162

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 11,001
Disposals (11,001 )
At 31 March 2023 -
NET BOOK VALUE
At 31 March 2023 -

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 15,209 23,586
Other debtors 33,943 35,907
49,152 59,493

7. CURRENT ASSET INVESTMENTS
31.3.23 31.3.22
£    £   
Unlisted investments 21,383 -

KDW ANAESTHESIA LTD (REGISTERED NUMBER: 11810677)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Taxation and social security 14,479 31,858
Other creditors 2,441 2,720
16,920 34,578

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

31.3.23 31.3.22
£    £   
K D Welsh and S Welsh
Balance outstanding at start of year 26,934 6,439
Amounts advanced 61,789 57,807
Amounts repaid (64,312 ) (37,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 24,411 26,934